Geometry.Net - the online learning center
Home  - Basic_E - Emphysema
e99.com Bookstore
  
Images 
Newsgroups
Page 8     141-158 of 158    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8 
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Emphysema:     more books (100)
  1. Living Well with Chronic Asthma, Bronchitis, and Emphysema A Couple Gude to Coping with Chronic Lung Disease by Myra B. (Shayevitz, Berton R.) Shayevitz, 1991
  2. Breathing control for asthma and emphysema by James L Livingstone, 1974

141. Centrilobular Emphysema
CENTRILOBULAR emphysema, GROSS The respiratory bronchioles and some alveolarducts in the proximal and middle portion of the pulmonary lobule are
http://www.som.tulane.edu/classware/pathology/medical_pathology/New_for_98/Lung_

142. Emphysema, Centrilobular (upper Zones), Panlobular (lower Zones)
emphysema, A CENTRILOBULAR (UPPER ZONES); AND B - PANACINAR (LOWER ZONES) In panacinar (panlobular) emphysema, there is involvement of the complete
http://www.som.tulane.edu/classware/pathology/medical_pathology/New_for_98/Lung_

143. Mayo Clinic: Chronic Obstructive Pulmonary Diseases (COPD) - Information And Tre
on chronic obstructive pulmonary diseases. Learn more about COPD, emphysemaand other lung diseases and research treatment options at mayoclinic.org.
http://www.mayoclinic.org/copd/
Home About Mayo Clinic Jobs Contact Us Mayo Clinic Locations: Arizona Florida Minnesota Mayo Clinic ... Medical Services Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease Overview Symptoms and Diagnosis Treatment Appointments ... Medical Services
Treatment of Chronic Obstructive Pulmonary Disease (COPD) at Mayo Clinic
(Synonyms: emphysema, chronic bronchitis, alpha-1 antitrypsin deficiency) Mayo Clinic is widely recognized for its expertise and experience in treating Chronic Obstructive Pulmonary Disease (COPD), which includes chronic obstructive bronchitis, emphysema and alpha-1 antitrypsin deficiency . Mayo's laboratory for testing lung function is the largest and most comprehensive of its kind and Mayo pulmonary specialists have broad experience in clinical trials of new medications for treatment of COPD.
Diagnosis
Chest X-rays, CT scans, pulmonary function tests and mucus examinations are among the tests used to diagnose COPD and determine the best treatment for the patient. Read more about diagnosis of COPD
Treatment Options
Treatment for COPD is based on the patient's general medical condition and severity of the disease. Therapies vary, from medication and oxygen, to transplant surgery in the cases. Mayo has special expertise in treatment of

144. RWJUH: Thoracic Center Of New Jersey
emphysema/Lung Volume Reduction Surgery Overview Over two million Americans areaffected by emphysema – one form of chronic obstructive pulmonary disease
http://www.rwjuh.edu/thoracic/emphysyma.html

Meet Our Staff
Lung Cancer Emphysema / Lung Volume Reduction Surgery Esophageal Surgery Center ... Thoracic Home COPD
Emphysema
Lung Volume Reduction Surgery
LVRS
Emphysema/Lung Volume Reduction Surgery
Overview
Causes

Cigarette smoking is the most important risk factor for emphysema. Pipe and cigarette smokers develop COPD more often than nonsmokers but not as often as cigarette smokers. In addition to smoking, other factors associated with the occurrence of COPD include environmental pollution by chemicals, secondary smoke, and hereditary tendencies.
Symptoms
Emphysema is characterized by a large barrel-shaped chest and shortness of breath. In the advanced stage, every breath is difficult. A cough may or not be present in individuals with emphysema. Diagnosis Physicians diagnose emphysema by physical examination, studies of pulmonary function, chest X-ray, blood tests, oxygen studies, and other non-invasive tests.

145. Emphysema News
emphysema News continually updated from thousands of sources around the net.
http://www.topix.net/health/emphysema
Advanced Search Enter ZIP, City or News Search
Emphysema News

146. BHF Any Questions? - Emphysema
The British Heart Foundation (BHF) is the leading national charity fighting heartand circulatory disease the UK s biggest killer. The BHF funds research,
http://www.bhf.org.uk/questions/index.asp?secondlevel=1171&thirdlevel=1369

147. Diseases - Alpha1-Antitrypsin Deficiency Or Inherited Emphysema - National Jewis
In about one out of every 50 cases of emphysema, there is a specific The inherited form of emphysema is called Alpha1 Antitrypsin Deficiency or Alpha
http://www.nationaljewish.org/disease-info/diseases/copd/about/alpha1-antitrypsi
Skip to Content
You are here:
National Jewish Home Disease Information Diseases We Treat Chronic Obstructive Pulmonary Disease ... About COPD Alpha1-Antitrypsin Deficiency More About:
About COPD
Questions?
Talk to a LUNG LINE nurse at
1-800-222-LUNG or
e-mail us
Alpha -Antitrypsin Deficiency or Inherited Emphysema
What is COPD?
C hronic o bstructive p ulmonary d isease or COPD for short, is a lung disease that affects millions of people each year. COPD is a general term used to describe diseases such as emphysema and chronic bronchitis. In emphysema there is damage to the walls of the air sacs (alveoli) in the lungs. The earliest symptom of emphysema is shortness of breath during activity. Later the shortness of breath can occur at rest also. What is Inherited Emphysema?
What Does the Alpha1 Protein do in the Body?

How is the Diagnosis Made?

How is Inherited Emphysema Managed?
...
What Does the Future Hold?
What is Inherited Emphysema?
Most cases of emphysema are caused by smoking or other environmental factors. There is growing evidence that genetics can also increase the risk of developing emphysema. In about one out of every 50 cases of emphysema, there is a specific hereditary basis for the disease.

148. National Emphysema Treatment Trial (NETT)
LVRS has been proposed as a treatment for patients with severe emphysema prior to On average, NETT found that patients with severe emphysema who undergo
http://mayoresearch.mayo.edu/mayo/research/pccm/national_emphysema_treatment_tri
Division of Pulmonary and Critical Care Medicine
division initiatives
Asthma Program Critical Care Service Division of Pulmonary and Critical Care Medicine - Clinical Trials Division of Pulmonary and Critical Care Medicine - Staff Directory ... Sleep Disorders Center
research staff
Faculty
clinical trials
See our clinical trials
National Emphysema Treatment Trial (NETT)
The NETT is a five-year, multicenter, randomized study evaluating the safety and effectiveness of lung volume reduction surgery (LVRS) in patients with severe emphysema. As many as two million Americans are estimated to have emphysema, a chronic disabling lung condition. LVRS has been proposed as a treatment for patients with severe emphysema prior to NETT. Insufficient evidence regarding the safety and effectiveness of the procedure led to a landmark collaboration among three federal agencies within the Department of Health and Human Services: the National Heart, Lung, and Blood Institute; the Centers for Medicare and Medicaid Services; and the Agency for Healthcare Research and Quality. The NETT is the product of that collaboration and may be the model for future evaluation of new medical interventions with large potential medical and financial impact. Key findings include:
  • Patients whose emphysema was predominantly in the upper lobes and whose exercise capacity was low after pulmonary rehabilitation were more likely to function better two years after the surgery then those who received only medical therapy. These patients also appear to have a survival advantage with LVRS.

149. Arizona Respiratory Center: Emphysema
emphysema is a disease in which much of the elastic network is destroyed. Currently there are there are 1.8 million Americans with emphysema,
http://www.resp-sci.arizona.edu/patient-info/adults/emphysema-a.htm
What You Should Know About
Emphysema breath is the main symptom of emphysema. In addition to the emphysema that is caused by smoking and inhalant irritants, it is estimated that 50,000 to 100,000 Americans living today were born with a deficiency of a protein known as alpha 1-antitrypsin (AAT) which can lead to an inherited form of emphysema called alpha 1-antitrypsin (AAT) deficiency-related emphysema. Understanding alpha1-antitrypsin
deficiency
emphysema Normally, the liver produces a protein called alpha1-antitrypsin (AAT) that protects the lungs from damage by certain of the body's enzymes. However, a small number of people of primarily northern European descent have a deficiency of AAT. As a result, their lungs aren't protected from the damaging enzymes, and they're almost certain to develop emphysema at an early age.
Usually, this form of emphysema starts when the affected person is between ages 20 and 40. Like the more common type of emphysema, it begins with shortness of breath during exercise. A blood test can reveal whether the problem is an AAT deficiency.

150. Lung Reduction Volume Surgery For Diffuse Emphysema
emphysema is a chronic lung disease, whereby walls of the air sacs Overview oflung volume reduction surgery for advanced emphysema, 26 October 2004
http://www.nice.org.uk/page.aspx?o=90647

151. After Surgery, Emphysema Patient Looks Forward To Spring Yard Work
emphysemasufferer and La Verne, California, resident Charlotte Kelley wishedfor the energy to go back to work, tend to her plants,
http://www.medicalnewstoday.com/medicalnews.php?newsid=24009

152. Emphysema - David L. Hoffmann B.Sc. (Hons), M.N.I.M.H. - HealthWorld Online, Hea
HealthWorld Online is the Internet s leading resource on alternative medicine,wellness, and mind/body health, featuring the Wellness Inventory whole person
http://www.healthy.net/library/books/hoffman/lowerrespitory/emphysema.htm
Herbal Medicine home alternative medicine health conditions healthy shopping ... contact us Tell A Friend Search enter keyword-click Health Conditions Abscess Acne ADD Addictions Aggressive Behavior Aging AIDS Alcoholism Allergic Rhinitis Allergies Alzheimer's Amenorrhea Anemia Angina Pectoris Anorexia Nervosa Anxiety Appendicitis Arthritis Asthma Atherosclerosis Athlete's Foot Autism Auto-Immune Backpain Bedwetting Birth Control Bladder Body Odor Boils Bowel Toxemia Breast Cancer Broken Bones Broken Teeth Bronchitis Bulimia Burns Bursitis Caffeine Addiction Cancer Candidiasis Cardiovascular Carpal Tunnel Cataracts Cerebrovascular Cervical Cancer Cervical Dysplasia Chemical Poison Chest Pain CHF Chicken Pox Children's Health Chlamydia Choking Cholecystitis Cholelithiasis Cholesterol Chronic Fatigue Chronic Pain Cold Extremities Colds and Flu Colic Conjunctivitis Constipation Corns Coughs Croup Cuts Cystitis Dandruff Dental Health Depression Dermotology Diabetes Diaper Rash Diarrhea Digestive Diverticulitis Diverticulosis Drug Addiction Dysmenorrhea Dysuria Ear Infections Eating Disorders Eczema Edema Elder Health Emphysema Endocrine Endometriosis Enlarged Prostate Epilepsy Esophagitis Eye Strain Fainting Fatigue Fear Fertility Fever Fibrocystic Breast Fibromyalgia Flatulence Flu Food Allergy Food Sensitivities Frostbite Fungal Infection Gall Bladder Gallstones Gastritis Gastroesophageal Gastrointestinal Gingivitis Glaucoma Gonorrhea Gout Hair Loss Hayfever Headaches Hearing Loss Heart Disease Heartburn Hematuria Hemorrhoids Hepatitis Herpes Simplex Herpes Zoster Hiccups High Blood Pres.

153. Testing A New Treatment For Emphysema: Currents: UI Health Care
Smoking is a proven etiologic factor for emphysema, with at least 20% of smokersdeveloping emphysema presents as increasing breathing difficulty.
http://www.uihealthcare.com/news/currents/vol5issue4/02emphysema.html

This issue home
CURRENTS Home Publishers Back Issues Send comments and questions to
staff@uihealthcare.com
University of Iowa, Iowa City, Iowa
Currents: Fall 2004, Volume 5, Number 4
Testing a new treatment for emphysema
Zlatko Anguelov, M.D. History: Emphysema is a type of Chronic Obstructive Pulmonary Disease characterized by peripheral lung destruction. The incidence of emphysema has increased over 40% since 1982. This common chronic lung disease kills 13,000 people in the U.S. every year, and at least 2.4 million Americans are estimated to be suffering from it. Smoking is a proven etiologic factor for emphysema, with at least 20% of smokers developing severe emphysema. Emphysema presents as increasing breathing difficulty. This is caused by the destruction of alveoli and bronchial tubes in the peripheral lung, which are then replaced by air spaces that increase in size over time. As the air spaces get larger, the lung functions less efficiently. As a result, the patient needs to breathe in more air to get the same amount of oxygen to the blood via the parts of the lung that are still functioning. This need for more air eventually leads to breathing difficulty, the air spaces enlarge, and the lungs and chest become overinflated. As the emphysema advances, the lung tissue in the affected lobes is gradually replaced with the enlarging air sacks that compress the normal lung.

154. Emphysema
emphysema is characterized by loss of the normal elasticity of the lung that helps to A major cause of both chronic bronchitis and emphysema is smoking.
http://www.wcax.com/Global/story.asp?S=1230438

155. Ivanhoe's Medical Breakthroughs - Solution For Emphysema
Solution for emphysema “Patients who have a survival advantage are those who Solution for emphysema That was a breath of fresh air for sufferers like
http://www.ivanhoe.com/channels/p_channelstory.cfm?storyid=9046

156. Emphysema
Penn State Hershey Medical Center provides world class care and services to patients.
http://www.hmc.psu.edu/healthinfo/e/emphysema.htm

157. NEJM -- Sign In
Editorial from The New England Journal of Medicine Surgery for emphysema Not for Everyone.
http://content.nejm.org/cgi/content/full/345/15/1126-a
// var NTPT_PGEXTRA = ''; // var NTPT_PGREFTOP = false; // var NTPT_NOINITIALTAG = false; CM8ShowAd("Topbanner");
HOME
SEARCH CURRENT ISSUE PAST ISSUES ... HELP Access to this article requires sign-in. Subscribers have access to all content.
Other registered users have access to research articles six months old and older. If you're a registered user or an activated subscriber
SIGN IN
User Name Password Forgot your Password? Click here and we'll e-mail it to you. If you do not use cookies, sign in here. Remember my User Name and Password. Log in via Athens. PURCHASE THIS ARTICLE Purchase a single article and get immediate online access for just $10. If you're a subscriber but have not yet activated your full online access
If you'd like to purchase a subscription to NEJM
If you're not a subscriber and want FREE limited access...
ACTIVATE YOUR SUBSCRIPTION
Subscribers to NEJM are entitled to full access to all online content and features, including 20 FREE online CME exams. OR Receive full access to ALL current content and online features including Personal Archives, PDF article downloads, PDA access, E-mail alerts and 20 FREE online CME exams.

158. Nikon MicroscopyU: Human Pathology Digital Image Gallery - Emphysema
Similar to most other respiratory ailments, smoking is a key factor in the onsetof emphysema, accounting for more than 80 percent of all cases of the
http://www.microscopyu.com/galleries/pathology/emphysema.html
MicroscopyU Site Map Small World Contest Interactive Tutorials Basic Concepts ... MicroscopyU Home Human Pathology Digital Image Gallery
Emphysema
In the 1980s, approximately 2 million Americans were known to be afflicted with the chronic respiratory disease emphysema. By the dawn of the twenty-first century that number had ballooned to 3 million. What is perhaps even more disconcerting, however, is that the vast majority of individuals diagnosed with emphysema could have avoided the crippling disease by simply not smoking cigarettes. Similar to most other respiratory ailments, smoking is a key factor in the onset of emphysema, accounting for more than 80 percent of all cases of the disease, which tends to develop gradually as the alveoli of the lungs become increasingly damaged by tobacco smoke. Thus, emphysema most commonly afflicts individuals over the age of 45, many of which began smoking as teenagers. The damage to the lungs caused by emphysema is irreversible. A successful lung transplant is the closest that a patient with the disease can currently come to a cure, but many individuals that such a procedure could potentially aid are not physically fit enough to undergo it. Accordingly, other, less invasive, treatments for emphysema are much more common. Bronchodilators are often recommended to help combat constriction of the airways, corticosteroids can soothe inflammation, and oxygen therapy is typically provided to individuals in an advanced state of the disease to counteract oxygen deficiency (

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 8     141-158 of 158    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8 

free hit counter